TG Therapeutics(DE:NKB2)
€56.60-1.60 (-2.75%)
DE:NKB2
TG Therapeutics earnings date
€56.60
At close:-1.60 (-2.75%)
TG Therapeutics (NKB2) Q2 2019 Earnings Report
3 Followers
DE:NKB2 Q2 2019 EPS Results
- Actual EPS
- -EUR 0.38
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.53
DE:NKB2 Q2 2019 Revenue Results
- Actual Revenue
- EUR 34.02K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +0.00%
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 08/09/2019
- Time
- Before Open
- Conference Call
- Friday, August 9, 2019
DE:NKB2 Upcoming Earnings
TG Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NKB2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 0.47- | 0.13 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | 0.320.31 | 2.18 | -85.60% (-1.86) | |
| Aug 03, 2026 | 2026 (Q2) | 0.270.04 | 0.15 | -70.59% (-0.11) | |
| May 06, 2026 | 2026 (Q1) | 0.250.11 | 0.03 | 300.00% (+0.08) | |
| Feb 26, 2026 | 2025 (Q4) | 0.320.13 | 0.13 | -6.67% (-0.01) | |
| Nov 03, 2025 | 2025 (Q3) | 0.202.18 | 0.02 | 12050.00% (+2.16) | |
| Aug 04, 2025 | 2025 (Q2) | 0.190.15 | 0.04 | 325.00% (+0.12) | |
| May 05, 2025 | 2025 (Q1) | 0.150.03 | -0.06 | 142.86% (+0.09) | |
| Mar 03, 2025 | 2024 (Q4) | 0.140.13 | -0.08 | 266.67% (+0.21) | |
| Nov 04, 2024 | 2024 (Q3) | 0.030.02 | 0.65 | -97.26% (-0.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

